- Home
- ARQQ vs MRVI Comparison
ARQQ vs MRVI Comparison
Compare ARQQ & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQQ
- MRVI
- Stock Information
- Founded
- ARQQ 2017
- MRVI 2014
- Country
- ARQQ United Kingdom
- MRVI United States
- Employees
- ARQQ N/A
- MRVI N/A
- Industry
- ARQQ Computer Software: Prepackaged Software
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- ARQQ Technology
- MRVI Health Care
- Exchange
- ARQQ Nasdaq
- MRVI Nasdaq
- Market Cap
- ARQQ 309.4M
- MRVI 312.4M
- IPO Year
- ARQQ N/A
- MRVI 2020
- Fundamental
- Price
- ARQQ $41.45
- MRVI $2.08
- Analyst Decision
- ARQQ Strong Buy
- MRVI Hold
- Analyst Count
- ARQQ 1
- MRVI 10
- Target Price
- ARQQ $52.00
- MRVI $6.84
- AVG Volume (30 Days)
- ARQQ 1.4M
- MRVI 1.5M
- Earning Date
- ARQQ 05-22-2025
- MRVI 08-06-2025
- Dividend Yield
- ARQQ N/A
- MRVI N/A
- EPS Growth
- ARQQ N/A
- MRVI N/A
- EPS
- ARQQ 0.48
- MRVI N/A
- Revenue
- ARQQ $241,000.00
- MRVI $241,856,000.00
- Revenue This Year
- ARQQ $1,818.77
- MRVI N/A
- Revenue Next Year
- ARQQ N/A
- MRVI $10.73
- P/E Ratio
- ARQQ $86.04
- MRVI N/A
- Revenue Growth
- ARQQ N/A
- MRVI N/A
- 52 Week Low
- ARQQ $3.72
- MRVI $1.67
- 52 Week High
- ARQQ $52.79
- MRVI $10.03
- Technical
- Relative Strength Index (RSI)
- ARQQ 76.17
- MRVI 46.40
- Support Level
- ARQQ $23.50
- MRVI $2.00
- Resistance Level
- ARQQ $28.44
- MRVI $2.44
- Average True Range (ATR)
- ARQQ 3.03
- MRVI 0.15
- MACD
- ARQQ 1.25
- MRVI -0.03
- Stochastic Oscillator
- ARQQ 83.95
- MRVI 20.45
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product QuantumCloud. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. The company operates and generates its revenue from UK.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.